Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep809 | Reproductive and Developmental Endocrinology | ECE2020

Computational study of the allosteric effects of the androgen receptor BF3 site mutations on steroid unbinding

Kotsikorou Evangelia , Dean Frank , Chowdhury Muniruzzaman

Experimental results have shown that the presence of endocrine disrupting chemicals (EDCs) such as the diphenyl compound DDT and its analogue DDE, allosterically cause the release of the stably bound dihydrotestosterone (DHT) from the steroid binding site of the Androgen Receptor (AR) ligand binding domain. It was hypothesized that EDCs mediate this effect via binding to the Binding Function 3 (BF3) surface binding site. Mutations of three BF 3 amino acids (F673K, F673W, G724R...

ea0090oc12.1 | Oral Communications 12: Environmental Endocrinology | ECE2023

Androgen Receptor Binding by DDE at the BF3 Site Favors Release of Bound Dihydrotestosterone

Tamez Angel , Bravo Naila , Garcia Emily , Dean Frank , Evanseck Jeffrey , Kotsikorou Evangelia

The androgen receptor (AR) function is inhibited by endocrine disrupting chemicals (EDCs) such as DDT and DDE leading to problems in embryonic development and negative health outcomes for adults. EDCs may bind in the steroid binding pocket and disrupt AR function by leading to altered receptor conformations. However, this may not be the only way EDCs interfere with the receptor. Estébanez-Perpiñá et al identified binding function 3 (BF3) as a surface bi...

ea0042p21 | (1) | Androgens2016

Investigating the role of SUMOylation of androgen receptor splice variants by SUMO1 in castration resistant prostate cancer

Kounatidou Evangelia E , Gaughan Luke

Prostate cancer (PC) is currently the most commonly diagnosed non-cutaneous cancer affecting UK men. Androgen deprivation therapy (ADT) has traditionally been used as the gold standard treatment for advanced PC. Despite the initial response to androgen ablation, tumours relapse and become refractory to clinically approved anti-androgens, resulting in castration-resistant PC (CRPC). In CRPC, androgen receptor (AR) signalling is inappropriately restored by AR splice variants (AR...

ea0039ep4 | Adrenal | BSPED2015

Discordance between the cortisol dose for replacement and that required for suppression of androstenedione (A4) and 17 hydroxyprogesterone (17OHP) in congenital adrenal hyperplasia

Charmandari Evangelia , Hindmarsh Peter

Androstenedione and 17OHP are often used as measures of cortisol replacement in congenital adrenal hyperplasia (CAH) rather than cortisol itself. Very little is known of the dose response relationships between cortisol and A4 and 17OHP.We have studied the relationship between 24 h serum cortisol, 17OHP and A4 in 33 (18M) children with CAH due to P450c21 deficiency. 24 h serum cortisol and 17OHP profiles were constructed using 20 min sampling intervals an...

ea0056gp264 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Thyroid function in pregnant women; relation to Gestational Diabetes Mellitus (GDM) and Body Mass Index (BMI)

Simeakis George , Vogiatzi Evangelia , Konstantakou Panagiota , Zapanti Evangelia , Saltiki Katerina , Alevizaki Maria , Anastasiou Eleni

Objectives: The interplay between thyroid function and metabolic state has been studied in many population subgroups. For pregnant women thyroid and metabolic parameters, including glucose homeostasis, are of great importance for a successful outcome. We examined aspects of thyroid function in relation to GDM and BMI in pregnant women referred to our Department.Methods: We studied 520 women during 24th – 32nd gestation week. De...

ea0056p1143 | Thyroid cancer | ECE2018

The significance of postoperative calcitonin (CT) levels in the evaluation of disease course in medullary thyroid cancer (MTC) patients

Saltiki Katerina , Simeakis George , Vogiatzi Evangelia , Kassi Eva , Zapanti Evangelia , Alevizaki Maria

Aim: Postoperative calcitonin (postCT) is a prognostic factor for disease progression in MTC patients. We evaluated the disease course in patients with persistently elevated post-CT.Methods: Of all MTC patients (n=273) followed-up in our Unit (for 1–37, median 7 years), 140 (39.3% men, 67.1% sporadicMTCs) had persistently elevated postCT (≥2.0 pg/ml). Clinical and biochemical data were recorded. Patients were classified in four groups...

ea0078OC6.4 | Oral Communications 6 | BSPED2021

Final height SDS of paediatric patients with ESRF that underwent renal transplantation

Gole Evangelia , Wilson Dominic , Muorah Mordi , Dias Renuka

Objective: Impaired linear growth is a common complication of end stage renal failure (ESRF), with recombinant human growth hormone (rhGH) being the suggested treatment until renal transplantation (RTx). Growth improvement post RTx has been reported, however data on the degree of catch up growth post RTx and final height (FH) is limited. We aimed to evaluate the effect of RTx on FH standard deviation score (SDS) and the possible contributing factors.Meth...

ea0081rc1.7 | Rapid Communications 1: Diabetes, Obesity, Metabolism and Nutrition 1 | ECE2022

The role of chemokines in type 1 diabetes-associated neuropathy

Baldimtsi Evangelia , Papadopoulou-Marketou Nektaria , Jenmalm Maria , Wahlberg Jeanette

Background and aims: Diabetic neuropathy is a common complication in patients with type 1 diabetes mellitus (T1D). In this study, we explore the importance of circulating chemokines for the development of diabetic neuropathy (DN) in T1D.Materials and methods: This study was a cross-sectional analysis of patients with childhood onset T1D followed prospectively in a long-term longitudinal cohort study. Fifty-two patients (20 women/32 men; mean age 28 &#177...

ea0050ep009 | Adrenal and Steroids | SFEBES2017

Pitfalls in the management of indeterminate adrenal masses

Vogiatzi Evangelia , Konstantakou Panagiota , Tzemeli Xakousti , Sykiotis Antonis , Ntali Georgia

Introduction A few adrenal masses may elude characterization on cross-sectional imaging and remain indeterminate. These include lipid-poor adenomas, adrenal metastases and carcinomas and phaeochromocytomas. It is important to distinguish between them, as phaeochromocytomas can be fatal if operated without preoperative blockade. Their clinical spectrum varies, from dramatic symptoms and signs including paroxysmal headache, flushing, diaphoresis, hyper...

ea0050ep009 | Adrenal and Steroids | SFEBES2017

Pitfalls in the management of indeterminate adrenal masses

Vogiatzi Evangelia , Konstantakou Panagiota , Tzemeli Xakousti , Sykiotis Antonis , Ntali Georgia

Introduction A few adrenal masses may elude characterization on cross-sectional imaging and remain indeterminate. These include lipid-poor adenomas, adrenal metastases and carcinomas and phaeochromocytomas. It is important to distinguish between them, as phaeochromocytomas can be fatal if operated without preoperative blockade. Their clinical spectrum varies, from dramatic symptoms and signs including paroxysmal headache, flushing, diaphoresis, hyper...